A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

Inclusion Criteria: * healthy male volunteers between the ages of 20 to 50 years old within the range of ±20% of IBW(Ideal Body Weight) * having neither congenital/chronic diseases nor pathological symptoms/findings as results of medical examination * doctor determines to be suitable as subjects within 4 weeks ago before administration Exclusion Criteria: * Hypersensitivity(or history of hypersensitivity) to amlodipine and valsartan * Active Liver Diseases or exceed 1.5 times the normal range of AST, ALT * Gastrointestinal diseases or surgeries that affect absorption of drug * Excessive drinking(exceed 30g/week) and excessive caffeine(exceed 250mg/day) * Smoking over 10 cigarettes per day